PD-1 and CTLA-4 as biomarkers for survival in kidney cancer

A recent study published in Journal of Clinical Medicine last month provides evidence for the expression of PD-1 and CTLA-4 receptors on white blood cells (tumour-infiltrating mononuclear cells) to be associated with a worse overall survival in patient with renal cell carcinoma (RCC). The combination of PD-1 and CTLA-4 expression in tumour-infiltrating mononuclear cells might […]

read more
Showing the single result